Abstract
Central pontine myelinolysis (CPM) is a non-inflammatory neurological condition with various clinical features and onset patterns and also with a very wide prognostic spectrum ranging from asymptomatic cases to encephalopathy and mortality. In this case report we, aim to present the first case of central pontine myelinolysis as a result of an optimally corrected hyponatremia in a post-COVID-19 patient our knowledge while assessing the clinical and radiological findings.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
